A Phase IIb, Randomized, Double-Blind, Placebo Controlled Study for the Treatment of Active Celiac Disease with AT-1001

  • Arsenescu, Razvan (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date5/1/0812/31/09